Recombinetics

11 articles about Recombinetics

• Recombinetics Inc. Announces Study to Improve Outcomes for Rare Disease Patients

  11/2/2020

  Recombinetics Inc., a leading gene editing company with platform technology applied to biomedicine and animal agriculture, today announced a first-of-its-kind study to improve outcomes for patients diagnosed with a rare disease known as Tuberous Sclerosis Complex (TSC). Surrogen, a subsidiary of Recombinetics Inc., is focused on d

• Recombinetics Inc. to Partner with American Preclinical Services to Improve Glioblastoma Outcomes

  10/19/2020

   Recombinetics Inc., a leading gene editing company with platform technology applied to biomedicine and animal agriculture, today announced that it has partnered with American Preclinical Services in a first of its kind study to improve Glioblastoma outcomes.

• Recombinetics Inc. Merges with Makana Therapeutics to Accelerate Xenotransplantation

  10/8/2020

  - Recombinetics Inc., a leading gene editing company with platform technology in therapeutics development, today announced that it has merged its efforts with Makana Therapeutics, a leader in the field of xenotransplantation.

• Recombinetics Announces New Chief Executive Officer

  2/11/2019

  Recombinetics, a pioneer in gene-editing solutions for human health and animal agriculture, today named Mark Platt the organization’s Chief Executive Officer.

• Recombinetics Closes $34 Million in Series A Funding

  8/21/2018

  Recombinetics, a pioneer in gene-editing solutions for human health and animal agriculture, today announced the completion of a $34 million Series A financing round.

• Recombinetics Release: Company Expands Its Scientific Advisory Board

  1/10/2017

• Recombinetics Closes $10 Million Stock Offering

  11/14/2016

• Recombinetics Awarded Two NIH Grants To Develop Humanized Swine Models Of Alzheimer's Disease And Neurofibromatosis 2

  10/13/2016

• Gene-Editing Startup Recombinetics Names Former General Mills Exec as CEO

  5/20/2016

• Recombinetics Release: First Published Research Shows Success With Targeted Gene-Editing to Accelerate Genetic Improvement in Dairy Cattle

  9/9/2013

• Cellectis BioResearch Grants Recombinetics an Exclusive License Agreement for the Use of Targeted Nucleases in Large Livestock

  8/24/2011